HCA SEC filings (2026)
CIK 860730 · Services-General Medical & Surgical Hospitals, NEC (SIC 8062) · fiscal year ends in December
3,520 filings on EDGAR since 1994 · 35 annual, 98 quarterly, 416 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
July 2026
- Jul 298-K8-K · New financial obligation; Other events
- Jul 28ReportQuarterly report, Q2 2026 — revenue $20.23B (+9% y/y), net income $1.70B, EPS $7.62
- Jul 24EarningsEarnings release — EPS $7.59 vs $7.57 est. (+0.3%); revenue $20.23B (+9% y/y) 1.5%
- Jul 148-K8-K · Results of operations; Regulation FD disclosure
June 2026
- Jun 188-K8-K · Directors or officers; compensation
April 2026
- Apr 308-K8-K · Material definitive agreement; New financial obligation; Other events
- Apr 29ReportQuarterly report, Q1 2026 — revenue $19.11B (+4% y/y), net income $1.62B, EPS $7.15
- Apr 288-K8-K · Shareholder vote results
- Apr 278-K8-K · HCA Announces Proposed PUBLIC Offering of Senior NotesOther events
- Apr 24EarningsEarnings release — EPS $7.15 vs $7.17 est. (−0.3%); revenue $19.11B (+4% y/y) 8.8%
March 2026
- Mar 13ProxyProxy · Annual report to shareholders
- Mar 13ProxyProxy · Additional proxy materials
- Mar 13ProxyProxy · Proxy statement
February 2026
- Feb 258-K8-K · Directors or officers; compensation
- Feb 18Insider saleMcAlevey Michael R (EVP & Chief Legal & Admin Off.) sold 1,694 shares for $904K at $533.37
- Feb 11Insider saleBerres Jennifer (SVP & Chief Human Res. Officer) sold 8,020 shares for $4.1M at $503.00–$526.16
- Feb 11Insider saleWyatt Christopher F. (SVP & Controller) sold 4,000 shares for $2.0M at $505.00
- Feb 10ReportAnnual report, FY2025 — revenue $75.60B (+7% y/y), net income $6.78B, EPS $28.33
- Feb 3Insider saleHAZEN SAMUEL N (CEO · Director) sold 42,877 shares for $21.5M at $497.18–$502.95
- Feb 3Insider saleCuffe Michael S. (EVP and Chief Clinical Officer) sold 1,500 shares for $747K at $498.09
January 2026
October 2025
- Oct 318-K8-K · Material definitive agreement; New financial obligation; Other events
- Oct 30ReportQuarterly report, Q3 2025 — revenue $19.16B (+10% y/y), net income $1.64B, EPS $6.96
- Oct 278-K8-K · HCA ANNOUNCES PROPOSED PUBLIC OFFERING OF SENIOR NOTESOther events
- Oct 24EarningsEarnings release — EPS $6.96 vs $5.65 est. (+23.2%); revenue $19.16B (+10% y/y) 1.6%
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $29.3M in 5 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Feb 18, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Sold · $904K · 1,694 sh |
| Feb 11, 2026Form 4 | Berres JenniferSVP & Chief Human Res. OfficerSold · $4.1M · 8,020 sh |
| Feb 11, 2026Form 4 | Wyatt Christopher F.SVP & ControllerSold · $2.0M · 4,000 sh |
| Feb 3, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorSold · $21.5M · 42,877 sh |
| Feb 3, 2026Form 4 | Cuffe Michael S.EVP and Chief Clinical OfficerSold · $747K · 1,500 sh |
Awards, exercises, withholding and plan purchases · 53 transactions
| Date | Insider |
|---|---|
| Aug 26, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Other · $3.3M · 7,769 sh |
| May 7, 2026Form 4 | Marks Mike AEVP and CFOGift · $0 · 6,672 sh |
| Apr 28, 2026Form 4 | FRIST THOMAS F IIIDirector · 10% ownerAward · $0 · 1,041 sh |
| Apr 28, 2026Form 4 | MICHELSON MICHAEL WDirectorAward · $0 · 925 sh |
| Apr 28, 2026Form 4 | Frist William RDirector · 10% ownerAward · $0 · 809 sh |
| Apr 28, 2026Form 4 | CHIDSEY JOHNDirectorAward · $0 · 809 sh |
| Apr 28, 2026Form 4 | Johnston Hugh FDirectorAward · $0 · 809 sh |
| Apr 28, 2026Form 4 | DEPARLE NANCY ANNDirectorAward · $0 · 509 sh |
| Apr 28, 2026Form 4 | Riley Wayne JosephDirectorAward · $0 · 509 sh |
| Apr 28, 2026Form 4 | Smith Andrea BDirectorAward · $0 · 509 sh |
| Feb 13, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Tax withholding · $1.8M · 3,306 sh |
| Feb 13, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Exercise or conversion · $1.2M · 5,000 sh |
| Feb 13, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Exercise or conversion · $0 · 5,000 sh |
| Feb 10, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorTax withholding · $10.7M · 21,323 sh |
| Feb 10, 2026Form 4 | Foster Jon MEVP and COOTax withholding · $3.0M · 5,888 sh |
| Feb 10, 2026Form 4 | Cuffe Michael S.EVP and Chief Clinical OfficerTax withholding · $1.8M · 3,501 sh |
| Feb 10, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Tax withholding · $1.5M · 3,006 sh |
| Feb 10, 2026Form 4 | Berres JenniferSVP & Chief Human Res. OfficerTax withholding · $1.3M · 2,515 sh |
| Feb 10, 2026Form 4 | Marks Mike AEVP and CFOTax withholding · $848K · 1,690 sh |
| Feb 10, 2026Form 4 | Wyatt Christopher F.SVP & ControllerTax withholding · $519K · 1,034 sh |
| Feb 10, 2026Form 4 | Rossitto EricaSVP & Chief Nurse ExecutiveTax withholding · $210K · 418 sh |
| Feb 10, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorAward · $0 · 54,934 sh |
| Feb 10, 2026Form 4 | Foster Jon MEVP and COOAward · $0 · 15,696 sh |
| Feb 10, 2026Form 4 | Cuffe Michael S.EVP and Chief Clinical OfficerAward · $0 · 9,628 sh |
| Feb 10, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Award · $0 · 8,372 sh |
| Feb 10, 2026Form 4 | Berres JenniferSVP & Chief Human Res. OfficerAward · $0 · 7,116 sh |
| Feb 10, 2026Form 4 | Marks Mike AEVP and CFOAward · $0 · 5,026 sh |
| Feb 10, 2026Form 4 | Wyatt Christopher F.SVP & ControllerAward · $0 · 3,350 sh |
| Feb 10, 2026Form 4 | Rossitto EricaSVP & Chief Nurse ExecutiveAward · $0 · 1,676 sh |
| Feb 6, 2026Form 4 | Frisco Holding II10% ownerOther · — · 73,186,329 sh |
| Feb 6, 2026Form 4 | Elcan Patricia F10% ownerOther · — · 73,186,329 sh |
| Feb 6, 2026Form 4 | FRIST THOMAS F IIIDirector · 10% ownerOther · — · 73,186,329 sh |
| Feb 6, 2026Form 4 | Frist William RDirector · 10% ownerOther · — · 73,186,329 sh |
| Feb 6, 2026Form 4 | FRIST THOMAS F JR10% ownerOther · — · 73,186,329 sh |
| Feb 6, 2026Form 4 | HERCULES HOLDING II10% ownerOther · $0 · 36,629,188 sh |
| Feb 5, 2026Form 4 | Foster Jon MEVP and COOTax withholding · $8.3M · 16,076 sh |
| Feb 5, 2026Form 4 | Foster Jon MEVP and COOExercise or conversion · $4.1M · 29,330 sh |
| Feb 5, 2026Form 4 | Wyatt Christopher F.SVP & ControllerTax withholding · $2.9M · 5,674 sh |
| Feb 5, 2026Form 4 | Wyatt Christopher F.SVP & ControllerExercise or conversion · $1.5M · 10,670 sh |
| Feb 5, 2026Form 4 | Foster Jon MEVP and COOExercise or conversion · $0 · 29,330 sh |
| Feb 5, 2026Form 4 | Wyatt Christopher F.SVP & ControllerExercise or conversion · $0 · 10,670 sh |
| Feb 4, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorOther · $1.0M · 2,090 sh |
| Feb 3, 2026Form 4 | Cuffe Michael S.EVP and Chief Clinical OfficerGift · $0 · 4,050 sh |
| Jan 30, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorTax withholding · $20.3M · 41,483 sh |
| Jan 30, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorExercise or conversion · $6.9M · 84,360 sh |
| Jan 30, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorExercise or conversion · $0 · 84,360 sh |
| Jan 29, 2026Form 4 | HAZEN SAMUEL NCEO · DirectorAward · $0 · 55,846 sh |
| Jan 29, 2026Form 4 | Foster Jon MEVP and COOAward · $0 · 11,945 sh |
| Jan 29, 2026Form 4 | Marks Mike AEVP and CFOAward · $0 · 11,945 sh |
| Jan 29, 2026Form 4 | Cuffe Michael S.EVP and Chief Clinical OfficerAward · $0 · 8,067 sh |
| Jan 29, 2026Form 4 | McAlevey Michael REVP & Chief Legal & Admin Off.Award · $0 · 8,067 sh |
| Jan 29, 2026Form 4 | Berres JenniferSVP & Chief Human Res. OfficerAward · $0 · 6,206 sh |
| Jan 29, 2026Form 4 | Wyatt Christopher F.SVP & ControllerAward · $0 · 2,560 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 16 filings
| Filed | What it is |
|---|---|
| Jul 29, 20268-K | New financial obligation; Other events |
| Jul 28, 202610-Q | Quarterly report, Q2 2026 — revenue $20.23B (+9% y/y), net income $1.70B, EPS $7.62 |
| Jul 24, 20268-K | Earnings release — EPS $7.59 vs $7.57 est. (+0.3%); revenue $20.23B (+9% y/y) 1.5% |
| Jul 14, 20268-K | Results of operations; Regulation FD disclosure |
| Jun 18, 20268-K | Directors or officers; compensation |
| Apr 30, 20268-K | Material definitive agreement; New financial obligation; Other events |
| Apr 29, 202610-Q | Quarterly report, Q1 2026 — revenue $19.11B (+4% y/y), net income $1.62B, EPS $7.15 |
| Apr 28, 20268-K | Shareholder vote results |
| Apr 27, 20268-K | HCA Announces Proposed PUBLIC Offering of Senior NotesOther events |
| Apr 24, 20268-K | Earnings release — EPS $7.15 vs $7.17 est. (−0.3%); revenue $19.11B (+4% y/y) 8.8% |
| Mar 13, 2026ARS | Annual report to shareholders |
| Mar 13, 2026DEFA14A | Additional proxy materials |
| Mar 13, 2026DEF 14A | Proxy statement |
| Feb 25, 20268-K | Directors or officers; compensation |
| Feb 10, 202610-K | Annual report, FY2025 — revenue $75.60B (+7% y/y), net income $6.78B, EPS $28.33 |
| Jan 27, 20268-K | Earnings release — EPS $8.01 vs $7.36 est. (+8.8%); revenue $19.51B (+7% y/y) 7.1% |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Oct 31, 20258-K | Material definitive agreement; New financial obligation; Other events |
| Oct 30, 202510-Q | Quarterly report, Q3 2025 — revenue $19.16B (+10% y/y), net income $1.64B, EPS $6.96 |
| Oct 27, 20258-K | HCA ANNOUNCES PROPOSED PUBLIC OFFERING OF SENIOR NOTESOther events |
| Oct 24, 20258-K | Earnings release — EPS $6.96 vs $5.65 est. (+23.2%); revenue $19.16B (+10% y/y) 1.6% |
| Aug 4, 202510-Q | Quarterly report, Q2 2025 — revenue $18.61B (+6% y/y), net income $1.65B, EPS $6.83 |
| Jul 25, 20258-K | Earnings release — EPS $6.84 vs $6.19 est. (+10.5%); revenue $18.61B (+6% y/y) 2.1% |
| Jul 11, 20258-K | Directors or officers; compensation |
| Jun 10, 20258-K | New financial obligation; Other events |
| May 1, 202510-Q | Quarterly report, Q1 2025 — revenue $18.32B (+6% y/y), net income $1.61B, EPS $6.45 |
| Apr 29, 20258-K | Directors or officers; compensation; Charter, bylaws or fiscal-year change; Shareholder vote results |
| Apr 25, 20258-K | Earnings release — EPS $6.45 vs $5.77 est. (+11.8%); revenue $18.32B (+6% y/y) 4.0% |
| Mar 14, 2025ARS | Annual report to shareholders |
| Mar 14, 2025DEFA14A | Additional proxy materials |
| Mar 14, 2025DEF 14A | Proxy statement |
| Mar 4, 2025PRE 14A | Preliminary proxy statement |
| Feb 24, 20258-K | Directors or officers; compensation |
| Feb 21, 20258-K | Material definitive agreement; New financial obligation; Other events |
| Feb 20, 20258-K | Material definitive agreement; Termination of a material agreement; New financial obligation |
| Feb 18, 20258-K | Other events |
| Feb 14, 202510-K | Annual report, FY2024 — revenue $70.60B (+9% y/y), net income $5.76B, EPS $22.00 |
| Jan 24, 20258-K | Earnings release — EPS $6.22 vs $5.97 est. (+4.2%); revenue $18.29B (+6% y/y) 3.8% |
2024 · 20 filings
| Filed | What it is |
|---|---|
| Oct 31, 202410-Q | Quarterly report, Q3 2024 — revenue $17.49B (+8% y/y), net income $1.27B, EPS $4.88 |
| Oct 25, 20248-K | Earnings release — EPS $5.05 vs $4.97 est. (+1.6%); revenue $17.49B (+8% y/y) 8.9% |
| Aug 12, 20248-K | Material definitive agreement; New financial obligation |
| Aug 8, 20248-K | Other events |
| Jul 29, 202410-Q | Quarterly report, Q2 2024 — revenue $17.49B (+10% y/y), net income $1.46B, EPS $5.53 |
| Jul 23, 20248-K | Earnings release — EPS $5.50 vs $4.97 est. (+10.7%); revenue $17.49B (+10% y/y) 4.5% |
| May 2, 202410-Q | Quarterly report, Q1 2024 — revenue $17.34B (+11% y/y), net income $1.59B, EPS $5.93 |
| Apr 30, 20248-K | Directors or officers; compensation; Shareholder vote results |
| Apr 26, 20248-K | Earnings release — EPS $5.36 vs $5.01 est. (+7.0%); revenue $17.34B (+11% y/y) 2.4% |
| Apr 5, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 27, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 15, 2024ARS | Annual report to shareholders |
| Mar 15, 2024DEFA14A | Additional proxy materials |
| Mar 15, 2024DEF 14A | Proxy statement |
| Feb 26, 20248-K/A | Directors or officers; compensation |
| Feb 26, 20248-K | Directors or officers; compensation |
| Feb 23, 20248-K | Material definitive agreement; New financial obligation |
| Feb 21, 20248-K | Other events |
| Feb 16, 202410-K | Annual report, FY2023 — revenue $64.97B (+8% y/y), net income $5.24B, EPS $18.97 |
| Jan 30, 20248-K | Earnings release — EPS $5.90 vs $5.05 est. (+16.8%); revenue $17.30B (+12% y/y) 5.2% |
2023 · 22 filings — 12 × 8-K, 3 × 10-Q, 2 × PX14A6G and 5 other forms
| Filed | What it is |
|---|---|
| Oct 26, 202310-Q | Quarterly report, Q3 2023 — revenue $16.21B (+8% y/y), net income $1.08B, EPS $3.91 |
| Aug 2, 202310-Q | Quarterly report, Q2 2023 — revenue $15.86B (+7% y/y), net income $1.19B, EPS $4.29 |
| Apr 27, 202310-Q | Quarterly report, Q1 2023 — revenue $15.59B (+4% y/y), net income $1.36B, EPS $4.85 |
| Apr 18, 2023PX14A6G | Shareholder exempt solicitation |
| Mar 28, 2023PX14A6G | Shareholder exempt solicitation |
| Mar 10, 2023ARS | Annual report to shareholders |
| Mar 10, 2023DEFA14A | Additional proxy materials |
| Mar 10, 2023DEF 14A | Proxy statement |
| Feb 17, 202310-K | Annual report, FY2022 — revenue $60.23B (+3% y/y), net income $5.64B, EPS $19.15 |
13 current reports (8-K) not listed; the year is on EDGAR.
2022 · 23 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202210-Q | Quarterly report, Q3 2022 — revenue $14.97B (−2% y/y), net income $1.13B, EPS $3.91 |
| Aug 1, 202210-Q | Quarterly report, Q2 2022 — revenue $14.82B (+3% y/y), net income $1.16B, EPS $3.90 |
| May 3, 202210-Q | Quarterly report, Q1 2022 — revenue $14.95B (+7% y/y), net income $1.27B, EPS $4.14 |
| Mar 25, 2022PX14A6N | Proxy statements |
| Mar 21, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 11, 2022DEFA14A | Additional proxy materials |
| Mar 11, 2022DEF 14A | Proxy statement |
| Feb 18, 202210-K | Annual report, FY2021 — revenue $58.75B (+14% y/y), net income $6.96B, EPS $21.16 |
15 current reports (8-K) not listed; the year is on EDGAR.
2021 · 21 filings — 10 × 8-K, 4 × PX14A6G, 3 × 10-Q and 3 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202110-Q | Quarterly report, Q3 2021 — revenue $15.28B (+15% y/y), net income $2.27B, EPS $7.00 |
| Aug 2, 202110-Q | Quarterly report, Q2 2021 — revenue $14.44B (+30% y/y), net income $1.45B, EPS $4.36 |
| Apr 30, 202110-Q | Quarterly report, Q1 2021 — revenue $13.98B (+9% y/y), net income $1.42B, EPS $4.14 |
| Apr 13, 2021PX14A6G | Shareholder exempt solicitation |
| Apr 7, 2021PX14A6G | Shareholder exempt solicitation |
| Apr 6, 2021DEFA14A | Additional proxy materials |
| Apr 2, 2021PX14A6G | Shareholder exempt solicitation |
| Apr 1, 2021PX14A6G | Shareholder exempt solicitation |
| Mar 19, 2021DEFA14A | Additional proxy materials |
| Mar 19, 2021DEF 14A | Proxy statement |
| Feb 19, 202110-K | Annual report, FY2020 — revenue $51.53B (+0% y/y), net income $3.75B, EPS $10.93 |
10 current reports (8-K) not listed; the year is on EDGAR.
2020 · 19 filings — 11 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 29, 202010-Q | Quarterly report, Q3 2020 — revenue $13.31B (+5% y/y), net income $668.0M, EPS $1.95 |
| Jul 30, 202010-Q | Quarterly report, Q2 2020 — revenue $11.07B (−12% y/y), net income $1.08B, EPS $3.16 |
| May 6, 202010-Q | Quarterly report, Q1 2020 — revenue $12.86B (+3% y/y), net income $581.0M, EPS $1.69 |
| Apr 9, 2020DEFA14A | Additional proxy materials |
| Mar 20, 2020DEFA14A | Additional proxy materials |
| Mar 20, 2020DEF 14A | Proxy statement |
| Mar 10, 2020PRE 14A | Preliminary proxy statement |
| Feb 20, 202010-K | Annual report, FY2019 — revenue $51.34B (+10% y/y), net income $3.50B, EPS $10.07 |
11 current reports (8-K) not listed; the year is on EDGAR.
2019 · 23 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201910-Q | Quarterly report, Q3 2019 — revenue $12.69B (+11% y/y), net income $612.0M, EPS $1.76 |
| Aug 2, 201910-Q | Quarterly report, Q2 2019 — revenue $12.60B (+9% y/y), net income $783.0M, EPS $2.25 |
| May 3, 201910-Q | Quarterly report, Q1 2019 — revenue $12.52B (+10% y/y), net income $1.04B, EPS $2.97 |
| Apr 9, 2019PX14A6G | Shareholder exempt solicitation |
| Mar 15, 2019DEFA14A | Additional proxy materials |
| Mar 15, 2019DEF 14A | Proxy statement |
| Mar 5, 2019PRE 14A | Preliminary proxy statement |
| Feb 21, 201910-K | Annual report, FY2018 — revenue $46.68B (+7% y/y), net income $3.79B, EPS $10.66 |
15 current reports (8-K) not listed; the year is on EDGAR.
2018 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201810-Q | Quarterly report, Q3 2018 — revenue $11.45B (+7% y/y), net income $759.0M, EPS $2.15 |
| Aug 3, 201810-Q | Quarterly report, Q2 2018 — revenue $11.53B (+7% y/y), net income $820.0M, EPS $2.31 |
| May 8, 201810-Q | Quarterly report, Q1 2018 — revenue $11.42B (+8% y/y), net income $1.14B, EPS $3.18 |
| Mar 16, 2018DEFA14A | Additional proxy materials |
| Mar 16, 2018DEF 14A | Proxy statement |
| Feb 23, 201810-K | Annual report, FY2017 — revenue $43.61B (+5% y/y), net income $2.22B, EPS $5.95 |
12 current reports (8-K) not listed; the year is on EDGAR.
2017 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 7, 201710-Q | Quarterly report, Q3 2017 — revenue $10.70B, net income $426.0M, EPS $1.15 |
| Aug 4, 201710-Q | Quarterly report, Q2 2017 — revenue $10.73B, net income $657.0M, EPS $1.75 |
| May 9, 201710-Q | Quarterly report, Q1 2017 — revenue $10.62B, net income $659.0M, EPS $1.74 |
| Mar 17, 2017DEFA14A | Additional proxy materials |
| Mar 17, 2017DEF 14A | Proxy statement |
| Mar 6, 2017PRE 14A | Preliminary proxy statement |
| Feb 22, 201710-K | Annual report, FY2016 — revenue $41.49B, net income $2.89B, EPS $7.30 |
15 current reports (8-K) not listed; the year is on EDGAR.
2016 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 26 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2014 · 31 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 24 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 27 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2011 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2010 · 16 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K
Counted, not listed; the year is on EDGAR.
2009 · 22 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2008 · 10 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K
Counted, not listed; the year is on EDGAR.
2007 · 10 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K
Counted, not listed; the year is on EDGAR.
2006 · 46 filings — 21 × 8-K, 14 × DEFA14A, 3 × 10-Q and 6 other forms
Counted, not listed; the year is on EDGAR.
2005 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 22 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2002 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K405 and 2 other forms
Counted, not listed; the year is on EDGAR.
2001 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
1999 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
1998 · 18 filings — 7 × 8-K, 3 × 10-Q, 3 × DFAN14A and 5 other forms
Counted, not listed; the year is on EDGAR.
1997 · 14 filings — 9 × 8-K, 2 × 10-Q, 1 × DEF 14A and 2 other forms
Counted, not listed; the year is on EDGAR.
1996 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1995 · 12 filings — 4 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
1994 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × 10-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 49 filings — 36 × 4, 4 × 144, 2 × 3 and 7 other forms
| Filed | What it is |
|---|---|
| Sep 11, 20263 | Initial insider holdings (Form 3) |
| Aug 28, 20264 | Insider transaction (Form 4) |
| May 11, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 20264 | Insider transaction (Form 4) |
| Apr 30, 2026SCHEDULE 13G | Other filings |
| Apr 29, 2026424B5 | Prospectus supplement |
| Apr 28, 2026FWP | Free writing prospectus |
| Apr 27, 2026424B3 | Prospectus |
| Apr 27, 2026S-3ASR | Automatic shelf registration |
| Mar 27, 2026SCHEDULE 13G/A | Other filings |
| Feb 18, 20264 | Insider transaction (Form 4) |
| Feb 18, 2026144 | Notice of proposed sale (Form 144) |
| Feb 12, 20264 | Insider transaction (Form 4) |
| Feb 12, 20264 | Insider transaction (Form 4) |
| Feb 12, 20264 | Insider transaction (Form 4) |
| Feb 12, 20264 | Insider transaction (Form 4) |
| Feb 12, 20264 | Insider transaction (Form 4) |
| Feb 12, 20264 | Insider transaction (Form 4) |
The newest 25 of 49 shown; the full year is on EDGAR.
2025 · 51 filings — 36 × 4, 6 × 144, 2 × 424B3 and 5 other forms
| Filed | What it is |
|---|---|
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 5, 20254 | Insider transaction (Form 4) |
| Nov 5, 20254 | Insider transaction (Form 4) |
| Nov 5, 2025144 | Notice of proposed sale (Form 144) |
| Nov 4, 20254 | Insider transaction (Form 4) |
| Oct 29, 2025424B5 | Prospectus supplement |
| Oct 27, 2025FWP | Free writing prospectus |
| Oct 27, 2025424B3 | Prospectus |
| Sep 8, 2025144 | Notice of proposed sale (Form 144) |
| Sep 8, 20254 | Insider transaction (Form 4) |
| Jul 31, 20254 | Insider transaction (Form 4) |
| Jul 18, 20253 | Initial insider holdings (Form 3) |
| Jun 23, 2025S-8 | Employee stock plan registration |
| May 15, 20254 | Insider transaction (Form 4) |
| May 15, 20254 | Insider transaction (Form 4) |
| May 13, 2025144 | Notice of proposed sale (Form 144) |
| May 8, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
| May 1, 20254 | Insider transaction (Form 4) |
The newest 25 of 51 shown; the full year is on EDGAR.
2024 · 121 filings — 84 × 4, 25 × 144, 5 × SC 13G/A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 14, 2024144 | Notice of proposed sale (Form 144) |
| Nov 14, 2024144 | Notice of proposed sale (Form 144) |
| Nov 14, 2024144 | Notice of proposed sale (Form 144) |
| Nov 13, 20244 | Insider transaction (Form 4) |
| Nov 1, 20244 | Insider transaction (Form 4) |
| Sep 12, 20244 | Insider transaction (Form 4) |
| Sep 12, 2024144 | Notice of proposed sale (Form 144) |
| Aug 12, 20244 | Insider transaction (Form 4) |
| Aug 9, 2024424B5 | Prospectus supplement |
| Aug 8, 20244 | Insider transaction (Form 4) |
| Aug 8, 2024FWP | Free writing prospectus |
| Aug 7, 20244 | Insider transaction (Form 4) |
| Aug 7, 2024424B3 | Prospectus |
| Aug 2, 20244 | Insider transaction (Form 4) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 31, 2024144 | Notice of proposed sale (Form 144) |
| Jul 29, 20244 | Insider transaction (Form 4) |
| Jul 29, 20244 | Insider transaction (Form 4) |
| Jul 29, 2024144 | Notice of proposed sale (Form 144) |
| Jul 29, 2024144 | Notice of proposed sale (Form 144) |
The newest 25 of 121 shown; the full year is on EDGAR.
2023 · 105 filings — 77 × 4, 7 × 144, 5 × SC 13G/A and 11 other forms
Counted, not listed; the year is on EDGAR.
2022 · 74 filings — 63 × 4, 5 × SC 13G/A, 3 × 5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2021 · 110 filings — 92 × 4, 6 × SC 13G/A, 5 × 5 and 6 other forms
Counted, not listed; the year is on EDGAR.
2020 · 98 filings — 84 × 4, 5 × 5, 4 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2019 · 121 filings — 100 × 4, 5 × 3, 5 × 5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2018 · 117 filings — 101 × 4, 5 × 5, 5 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2017 · 135 filings — 115 × 4, 5 × 5, 4 × SC 13G/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2016 · 119 filings — 98 × 4, 5 × 5, 4 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2015 · 136 filings — 106 × 4, 6 × 5, 5 × FWP and 6 other forms
Counted, not listed; the year is on EDGAR.
2014 · 123 filings — 97 × 4, 5 × 3, 5 × 5 and 8 other forms
Counted, not listed; the year is on EDGAR.
2013 · 148 filings — 138 × 4, 5 × SC 13G/A, 3 × 424B7 and 2 other forms
Counted, not listed; the year is on EDGAR.
2012 · 144 filings — 114 × 4, 5 × SC 13G/A, 3 × 3 and 9 other forms
Counted, not listed; the year is on EDGAR.
2011 · 141 filings — 104 × 4, 5 × 3, 4 × 5 and 17 other forms
Counted, not listed; the year is on EDGAR.
2010 · 58 filings — 29 × 4, 12 × 424B3, 2 × DEF 14C and 13 other forms
Counted, not listed; the year is on EDGAR.
2009 · 83 filings — 45 × 4, 8 × 424B3, 6 × 3 and 10 other forms
Counted, not listed; the year is on EDGAR.
2008 · 53 filings — 45 × 3, 5 × 4, 1 × 8-A12G and 2 other forms
Counted, not listed; the year is on EDGAR.
2007 · 5 filings — 1 × 424B3, 1 × EFFECT, 1 × S-4 and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 247 filings — 211 × 4, 5 × SC 13E3/A, 5 × UPLOAD and 19 other forms
Counted, not listed; the year is on EDGAR.
2005 · 245 filings — 223 × 4, 6 × SC TO-I/A, 4 × 3 and 10 other forms
Counted, not listed; the year is on EDGAR.
2004 · 182 filings — 155 × 4, 6 × SC TO-I/A, 3 × 11-K and 10 other forms
Counted, not listed; the year is on EDGAR.
2003 · 82 filings — 70 × 4, 3 × 11-K, 3 × 424B2 and 4 other forms
Counted, not listed; the year is on EDGAR.
2002 · 16 filings — 3 × NO ACT, 3 × S-3/A, 3 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2001 · 7 filings — 3 × SC 13G, 1 × 424B2, 1 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 16 filings — 3 × 424B5, 3 × S-8, 3 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
1999 · 9 filings — 3 × SC 13G/A, 1 × 424B3, 1 × RW and 4 other forms
Counted, not listed; the year is on EDGAR.
1998 · 6 filings — 2 × SC 13G, 2 × SC 13G/A, 1 × 4 and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 8 filings — 2 × SC 13G/A, 1 × 4, 1 × 424B2 and 4 other forms
Counted, not listed; the year is on EDGAR.
1996 · 11 filings — 5 × 424B2, 2 × 15-15D, 1 × S-3 and 3 other forms
Counted, not listed; the year is on EDGAR.
1995 · 25 filings — 9 × 424B2, 2 × S-4 POS, 2 × S-4/A and 11 other forms
Counted, not listed; the year is on EDGAR.
1994 · 24 filings — 6 × 424B2, 3 × S-3, 3 × S-8 and 7 other forms
Counted, not listed; the year is on EDGAR.
About this data#
HCA Healthcare Inc. (HCA) has 3,520 filings on EDGAR going back to 1994: 35 annual reports, 98 quarterly reports and 416 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Jul 29, 2026, covered new financial obligation; other events. Over the last 13 months insiders sold $29.3M in 5 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been HCA Healthcare Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read HCA's latest 10-K?
- HCA's latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did HCA last file an 8-K?
- On Jul 29, 2026 it covered new financial obligation; other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 24, 2026.
- Are HCA insiders buying or selling?
- Over the last 13 months insiders sold $29.3M in 5 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: McAlevey Michael R (EVP & Chief Legal & Admin Off.) sold 1,694 shares on Feb 18, 2026 for $904K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has HCA made?
- 3,520 filings are on EDGAR under the registrant records that have been HCA Healthcare Inc., going back to 1994; 2,405 of them are insider ownership forms (Forms 3, 4, 5 and 144).